Sort
30,917 grants matching “tumor microenvironment”
Biospecimen and Data Core
$293,669Joseph B Shrager · Stanford University · U54 · FY2024 · CA
Macrophage Dysfunction in Immunosenescence
$293,666University Of Louisville · R01 · FY2004 · AG
Metabolic implications of radiation response in oligometastatic prostate cancer.
$293,664Nicole L Simone · University Of Maryland Baltimore · U54 · FY2022 · CA
GENETIC ALTERATION IN THE EPITHELIAL AND STROMAL
$293,658Charis Eng · Ohio State University · P01 · FY2006 · CA
Chemokine Signals in the Premetastatic Niche Inhibit Metastasis
$293,555Ann Richmond · Vanderbilt University · R01 · FY2017 · CA
Chemokine Signals in the Premetastatic Niche Inhibit Metastasis
$293,555Ann Richmond · Vanderbilt University · R01 · FY2016 · CA
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer
$293,541Douglas Hanahan · Dana-Farber Cancer Inst · P01 · FY2008 · CA
MITF: Regulating Osteoclast Gene Expression and Function
$293,475Michael C Ostrowski · Medical University Of South Carolina · R01 · FY2017 · AR
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
$293,471Michael S Goligorsky · New York Medical College · R01 · FY2007 · DK
Modulation of sensitivity & imaging therapeutic response of hypoxic cancer cells
$293,448Wafik S El-Deiry · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2013 · CA
AUTOCRINE AND PARACRINE OF HOMEOSTASIS OF THE INTERVERTEBRAL DISC
$293,400Koichi Masuda · Rush University Medical Center · P01 · FY2009 · AR
Mechanisms of Cell-Cell Interaction in Tumor Growth and Metastasis in Flies
$293,351Tian Xu · Yale University · R01 · FY2014 · CA
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man
$293,290Richard C Koya · Roswell Park Cancer Institute Corp · R01 · FY2013 · CA
Evading Immune Escape Mechanisms in Dual-Targeted T-cell Therapy for Breast Canc
$293,263Juan Fernando Vera · Baylor College Of Medicine · P50 · FY2018 · CA
Core 2: ImmunoPhenotyping Core
$293,233Ata Saba Moshiri · University Of Washington · P01 · FY2022 · CA
Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors
$293,197Yuanpei Li · University Of California At Davis · R01 · FY2020 · HD
Novel Drug for Cancer Immunotherapy that Targets Phosphatidylserine
$293,178Richard B Bankert · Immune Modulatory Therapies, Llc · R43 · FY2021 · CA
Arginase Production in Cancer: Evading Immune Response
$293,150Louisiana State Univ Hsc New Orleans · R01 · FY2004 · CA
Core 2: Human Specimen and Organic Core (HSO Core)
$293,113Herve Tiriac · Salk Institute For Biological Studies · P01 · FY2023 · CA
Role of Focal Adhesion Kinase In Tumorigenesis
$293,090David D Schlaepfer · University Of California, San Diego · R01 · FY2012 · CA
Role of Focal Adhesion Kinase In Tumorigenesis
$293,090David D Schlaepfer · University Of California, San Diego · R01 · FY2011 · CA
THE ROLE OF LYMPHOID MICROENVIRONMENT IN AUTOIMMUNITY
$293,045University Of Chicago · R01 · FY2001 · DK
MAPK pathway modulation in thyroid tumorigenesis
$293,045Aime T. Franco · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Pilot in vivo trial with T-cell-based delivery of immunostimulatory proteins
$293,028Harikrishnan Radhakrishnan · Sri International · R21 · FY2024 · CA
Core 2: ImmunoPhenotyping Core
$293,016Ata Saba Moshiri · University Of Washington · P01 · FY2023 · CA